0000950170-24-026715.txt : 20240305 0000950170-24-026715.hdr.sgml : 20240305 20240305204415 ACCESSION NUMBER: 0000950170-24-026715 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bylund James CENTRAL INDEX KEY: 0001849642 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 24724033 MAIL ADDRESS: STREET 1: C/O REPLIGEN CORPORATION STREET 2: 41 SYON ST. BLDG. SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 ownership.xml 4 X0508 4 2024-03-01 0000730272 REPLIGEN CORP RGEN 0001849642 Bylund James C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 false true false false Chief Operating Officer false Common Stock 2024-03-01 4 A false 50 0.00 A 22460 D Represents 50 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on May 16, 2023. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. /s/ Kimberly Brown (Attorney in Fact) 2024-03-05